rts logo

Is Ironwood Pharmaceuticals Inc (IRWD) a good stock to buy now?

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) is -28.15% lower on its value in year-to-date trading and has touched a low of $8.07 and a high of $15.70 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IRWD stock was last observed hovering at around $8.61 in the last trading session, with the day’s loss setting it -0.39%.

Currently trading at $8.22, the stock is -6.77% and -31.60% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.21 million and changing -4.53% at the moment leaves the stock -22.42% off its SMA200. IRWD registered -21.11% loss for a year compared to 6-month loss of -14.64%. The firm has a 50-day simple moving average (SMA 50) of $4.31 and a 200-day simple moving average (SMA200) of -$2.07.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The stock witnessed a -9.32% gain in the last 1 month and extending the period to 3 months gives it a -28.15%, and is -2.26% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.97% over the week and 4.90% over the month.

Ironwood Pharmaceuticals Inc (IRWD) has around 267 employees, a market worth around $1.29B and $442.74M in sales. Fwd P/E is 10.31. Profit margin for the company is -226.37%. Distance from 52-week low is 1.80% and -47.64% from its 52-week high. The company has generated returns on investments over the last 12 months (-601.74%).

Ironwood Pharmaceuticals Inc quarterly earnings per share for the current quarter are estimated at $0.2 with sales reaching $106.3M over the same period.The EPS is expected to grow by 110.57% this year, but quarterly earnings will post 1.30% year-over-year. Quarterly sales are estimated to grow 5.90% in year-over-year returns.

Ironwood Pharmaceuticals Inc (IRWD) Top Institutional Holders

366 institutions hold shares in Ironwood Pharmaceuticals Inc (IRWD), with institutional investors hold 111.19% of the company’s shares. The shares outstanding are 156.35M, and float is at 151.60M with Short Float at 12.38%. Institutions hold 108.88% of the Float.

The top institutional shareholder in the company is Blackrock Inc. with over 25.8 million shares valued at $274.56 million. The investor’s holdings represent 16.54% of the IRWD Shares outstanding. As of Jun 29, 2023, the second largest holder is Sarissa Capital Management, LP with 16.39 million shares valued at $174.39 million to account for 10.50% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 14.85 million shares representing 9.52% and valued at over $157.97 million, while State Street Corporation holds 7.07% of the shares totaling 11.03 million with a market value of $117.34 million.

Ironwood Pharmaceuticals Inc (IRWD) Insider Activity

The most recent transaction is an insider purchase by Duane Jon R,the company’sDirector. SEC filings show that Duane Jon R bought 6,920 shares of the company’s common stock on Mar 06 ’24 at a price of $8.70 per share for a total of $60204.0. Following the purchase, the insider now owns 0.12 million shares.

Ironwood Pharmaceuticals Inc disclosed in a document filed with the SEC on Mar 04 ’24 that Emany Sravan Kumar (SVP, Chief Financial Officer) bought a total of 10,684 shares of the company’s common stock. The trade occurred on Mar 04 ’24 and was made at $9.38 per share for $0.1 million. Following the transaction, the insider now directly holds 0.3 million shares of the IRWD stock.

Still, SEC filings show that on Feb 12 ’24, MCCOURT Thomas A (Chief Executive Officer) disposed off 177,164 shares at an average price of $15.24 for $2.7 million. The insider now directly holds 832,774 shares of Ironwood Pharmaceuticals Inc (IRWD).

Related Posts